News is out! Go SCRC! Tut ScripsAmerica's Speci
Post# of 7769
Posted On: 06/02/2014 8:41:41 AM
News is out! Go SCRC! Tut
ScripsAmerica's Specialty Pharmacy Records Monthly Revenue of $1.6 Million in May
Scripsamerica (QB) (OTCBB:SCRC)
Intraday Stock Chart
Today : Monday 2 June 2014
ScripsAmerica's Specialty Pharmacy Records Monthly Revenue of $1.6 Million in May
TYSONS CORNER, VA--(Marketwired - Jun 2, 2014) - ScripsAmerica, Inc. (OTCBB: SCRC) today announced that its managed specialty pharmacy reported $1.6 million in prescription sales during the month of May.
Main Avenue Pharmacy's $1.6 million in monthly revenue for May represents a 67% increase over April's revenue and 224% increase over March's revenue. ScripsAmerica fully manages the operations of the specialty pharmacy, which focuses on compounding topical creams. May's sales have significantly increased Main Avenue Pharmacy's annual run rate to $19.2 million.
"ScripsAmerica is pleased to report that Main Avenue Pharmacy's revenue is continuing its aggressive monthly revenue growth and has already generated $3.2 million for the Company since we began managing its operations just over three months ago. This new area of business will increase our shareholder value as the pharmacy's compounded topical pain creams continue to see growing demand and expands its sales into new states," commented ScripsAmerica's CEO, Bob Schneiderman.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact:
Seal Point Consulting
888-959-7095
Email Contact
ScripsAmerica's Specialty Pharmacy Records Monthly Revenue of $1.6 Million in May
Scripsamerica (QB) (OTCBB:SCRC)
Intraday Stock Chart
Today : Monday 2 June 2014
ScripsAmerica's Specialty Pharmacy Records Monthly Revenue of $1.6 Million in May
TYSONS CORNER, VA--(Marketwired - Jun 2, 2014) - ScripsAmerica, Inc. (OTCBB: SCRC) today announced that its managed specialty pharmacy reported $1.6 million in prescription sales during the month of May.
Main Avenue Pharmacy's $1.6 million in monthly revenue for May represents a 67% increase over April's revenue and 224% increase over March's revenue. ScripsAmerica fully manages the operations of the specialty pharmacy, which focuses on compounding topical creams. May's sales have significantly increased Main Avenue Pharmacy's annual run rate to $19.2 million.
"ScripsAmerica is pleased to report that Main Avenue Pharmacy's revenue is continuing its aggressive monthly revenue growth and has already generated $3.2 million for the Company since we began managing its operations just over three months ago. This new area of business will increase our shareholder value as the pharmacy's compounded topical pain creams continue to see growing demand and expands its sales into new states," commented ScripsAmerica's CEO, Bob Schneiderman.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact:
Seal Point Consulting
888-959-7095
Email Contact
(0)
(0)ScripsAmerica Inc (SCRC) Stock Research Links
Scroll down for more posts ▼